Hospital surfaces are breeding grounds for dangerous bacteria. Now, researchers believe a special paint could be the answer ...

Acurx Pharmaceuticals, Inc. ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections, today ...

Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, Shandong 264117, China ...

The Staten Island, New York-based company also develops ACX-375C, a potential treatment for gram-positive bacteria, including resistant strains like MRSA and VRE. It ranks first among 10 micro-cap ...

The Staten Island, New York-based company also develops ACX-375C, a potential treatment for gram-positive bacteria, including resistant strains like MRSA and VRE. It ranks first among 10 micro-cap ...

Methicillin-resistant Staphylococcus aureus (MRSA) is a major concern due to its high mortality rate and resistance to several medications used to treat common staph infections. 3 Between 2017 and ...

Vancomycin-resistant enterococci are a particular ... Infective endocarditis; LD: Loading dose; MRSA: Methicillin-resistant Staphylococcus aureus; MU: Million units; NVE: Native valve endocarditis ...

Once sample was taken, we shifted to another regimen of antibiotics (vancomycin and meropenem) till culture results appear. Radiological data was obtained in the form of CT or MR imaging with findings ...

MRSA colonization; Household transmission; Community-acquired MRSA (CA-MRSA); Spontaneous clearance; Antibiotic resistance; Infection control; Nasal carriage We evaluated household colonization in ...